Treatment for IBS-C
Start all patients with lifestyle modifications (regular exercise) and first-line dietary advice, then escalate to soluble fiber (ispaghula 3-4g/day, titrated gradually), and if symptoms persist, use secretagogues as second-line therapy, with linaclotide being the most efficacious option for IBS-C. 1
First-Line Approach
Lifestyle and Dietary Interventions
- Regular exercise should be advised for all patients 1
- First-line dietary advice is essential and should be offered universally 1
- Soluble fiber (ispaghula) is effective for global symptoms and abdominal pain:
- Start at low dose (3-4 g/day) and build up gradually to avoid bloating
- Avoid insoluble fiber (e.g., wheat bran) as it may worsen symptoms 1
Second-Line Dietary Therapy
- Low FODMAP diet can be effective for global symptoms and abdominal pain, but:
- Must be supervised by a trained dietitian
- FODMAPs should be reintroduced according to tolerance
- Evidence quality is very low 1
Probiotics
- May be effective as a group for global symptoms and abdominal pain
- No specific species or strain can be recommended
- Reasonable to trial for up to 12 weeks and discontinue if no improvement 1
Second-Line Pharmacological Therapy
Secretagogues (Most Effective for IBS-C)
Linaclotide (guanylate cyclase-C agonist):
- Likely the most efficacious secretagogue available for IBS-C 1
- Strong recommendation with high-quality evidence 1
- Common side effect: diarrhea 1
- Improves both motility and sensory symptoms 2
Lubiprostone (chloride channel activator):
- Efficacious second-line drug with moderate-quality evidence 3, 1
- FDA-approved for women with IBS-C at 8 mg twice daily 3
- Less likely to cause diarrhea than other secretagogues
- Common side effect: nausea (patients should be warned) 1
- Superior to placebo for global response and abdominal pain, though differences may not meet clinically meaningful thresholds 3
Tenapanor (sodium-hydrogen exchange inhibitor):
- Efficacious with high-quality evidence 1
- Strong recommendation 1
- Common side effect: diarrhea 1
- Licensed in USA but not available in many countries 1
Plecanatide (guanylate cyclase-C agonist):
- Efficacious second-line drug 1
- Weak recommendation with very low-quality evidence 1
- Diarrhea is common and no less likely than with linaclotide or tenapanor 1
Tegaserod (5-HT4 receptor agonist):
- Efficacious with moderate-quality evidence 3, 1
- FDA-approved only for women under 65 years without cardiovascular disease 3
- Conditional recommendation due to cardiovascular safety concerns 3
- Unavailable outside the USA 1
- Common side effect: diarrhea 1
Third-Line: Gut-Brain Neuromodulators
For Persistent Abdominal Pain
Tricyclic Antidepressants (TCAs):
- Effective for global symptoms and abdominal pain with moderate-quality evidence 1
- Strong recommendation 1
- Start amitriptyline 10 mg once daily, titrate slowly to maximum 30-50 mg once daily 1
- Can be initiated in primary or secondary care
- Critical: Explain rationale as gut-brain neuromodulators, not antidepressants
- Counsel about side effects (dry mouth, visual disturbance, dizziness)
Selective Serotonin Reuptake Inhibitors (SSRIs):
- May be effective for global symptoms with low-quality evidence 1
- Weak recommendation 1
- Same counseling approach as TCAs required
Additional Considerations
Antispasmodics
- May be effective for global symptoms and abdominal pain 1
- Weak recommendation with very low-quality evidence 1
- Common side effects: dry mouth, visual disturbance, dizziness 1
Brain-Gut Behavioral Therapies
- IBS-specific cognitive behavioral therapy may be efficacious 1
- Consider for patients with persistent symptoms or psychological comorbidity 4, 5
Treatment Algorithm
- All patients: Exercise + first-line dietary advice + soluble fiber (ispaghula)
- If inadequate response: Low FODMAP diet (with dietitian supervision)
- If still inadequate: Secretagogues (linaclotide preferred for efficacy)
- For persistent abdominal pain: Add TCAs (amitriptyline 10-50 mg)
- Refractory cases: Consider brain-gut behavioral therapies
Important Caveats
- Avoid insoluble fiber - it worsens symptoms 1
- Gluten-free diets are not recommended 1
- IgG antibody-based food elimination diets are not recommended 1
- Secretagogues commonly cause diarrhea - this is dose-dependent and may require titration 1, 4
- Lubiprostone causes nausea more frequently than diarrhea 1
- Tegaserod has cardiovascular restrictions - only for women <65 without CV disease 3
- When prescribing neuromodulators, always explain they are being used for gut-brain axis modulation, not depression 1